3.72 (-%)
As of Dec 06, 2024
Source:
Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution , is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis .
Country | United States |
Headquarters | langhorne, texas |
Phone Number | (512) 614-1848 |
Industry | manufacturing |
CEO | Matthew Pauls |
Website | www.savarapharma.com |